Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.69B | 20.66B | 20.55B | 19.17B | 19.48B | 17.64B |
Gross Profit | 10.60B | 8.21B | 7.80B | 7.05B | 7.27B | 6.23B |
EBITDA | 4.62B | 6.89B | 3.39B | 3.08B | 3.67B | 2.53B |
Net Income | 1.48B | 3.20B | 611.00M | 411.00M | 914.00M | 399.00M |
Balance Sheet | ||||||
Total Assets | 28.70B | 28.94B | 28.31B | 27.16B | 27.58B | 27.11B |
Cash, Cash Equivalents and Short-Term Investments | 2.63B | 3.02B | 1.23B | 858.00M | 2.36B | 2.45B |
Total Debt | 13.18B | 13.17B | 15.00B | 15.08B | 15.65B | 15.72B |
Total Liabilities | 20.40B | 20.39B | 22.80B | 22.55B | 23.32B | 24.22B |
Stockholders Equity | 3.75B | 4.17B | 1.61B | 1.14B | 1.03B | 28.00M |
Cash Flow | ||||||
Free Cash Flow | 1.56B | 1.12B | 1.62B | 321.00M | 910.00M | 2.87B |
Operating Cash Flow | 2.46B | 2.05B | 2.37B | 1.08B | 1.57B | 3.41B |
Investing Cash Flow | -267.00M | 3.25B | -969.00M | -808.00M | -714.00M | -1.61B |
Financing Cash Flow | -2.45B | -3.51B | -1.03B | -1.78B | -936.00M | 385.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $12.10B | 10.01 | 18.66% | 0.42% | 9.61% | 39.65% | |
75 Outperform | $17.33B | 12.56 | 41.09% | ― | -1.09% | -43.10% | |
73 Outperform | $12.65B | 24.55 | 25.35% | 0.54% | 11.80% | 30.02% | |
71 Outperform | $14.43B | 20.18 | 4.72% | 3.18% | 1.11% | 25.84% | |
71 Outperform | $98.46B | 17.67 | -230.22% | 0.66% | 6.37% | 11.25% | |
62 Neutral | $9.86B | 13.55 | 635.30% | ― | 5.09% | 7.85% | |
51 Neutral | $7.95B | -0.40 | -42.50% | 2.21% | 22.29% | -1.85% |
On May 30, 2025, Tenet Healthcare Corporation announced the promotion of Lisa Y. Foo to the newly created position of Chief Operating Officer, effective immediately. This strategic move is expected to enhance the company’s operational leadership and potentially strengthen its market position.